186 related articles for article (PubMed ID: 28981353)
1. Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
Lee MA; Cho SH; Seo AN; Kim HJ; Shin KM; Kim SH; Choi GS
AJR Am J Roentgenol; 2017 Dec; 209(6):1247-1255. PubMed ID: 28981353
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
Yoen H; Park HE; Kim SH; Yoon JH; Hur BY; Bae JS; Kim JH; Oh HJ; Han JK
Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
4. Value of percent change in tumoral volume measured at T
Quaia E; Gennari AG; Ricciardi MC; Ulcigrai V; Angileri R; Cova MA
J Magn Reson Imaging; 2016 Dec; 44(6):1415-1424. PubMed ID: 27219471
[TBL] [Abstract][Full Text] [Related]
5. Image Quality Assessment of 2D
Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
[TBL] [Abstract][Full Text] [Related]
6. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
[No Abstract] [Full Text] [Related]
7. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer.
Kim YC; Lim JS; Keum KC; Kim KA; Myoung S; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW
J Magn Reson Imaging; 2011 Sep; 34(3):570-6. PubMed ID: 21751285
[TBL] [Abstract][Full Text] [Related]
8. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
Sclafani F; Brown G; Cunningham D; Wotherspoon A; Mendes LST; Balyasnikova S; Evans J; Peckitt C; Begum R; Tait D; Tabernero J; Glimelius B; Roselló S; Thomas J; Oates J; Chau I
Br J Cancer; 2017 Nov; 117(10):1478-1485. PubMed ID: 28934761
[TBL] [Abstract][Full Text] [Related]
9. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer: A Feasibility Study.
Jacobs L; Intven M; van Lelyveld N; Philippens M; Burbach M; Seldenrijk K; Los M; Reerink O
Ann Surg; 2016 Mar; 263(3):522-8. PubMed ID: 26106836
[TBL] [Abstract][Full Text] [Related]
11. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
Battersby NJ; Dattani M; Rao S; Cunningham D; Tait D; Adams R; Moran BJ; Khakoo S; Tekkis P; Rasheed S; Mirnezami A; Quirke P; West NP; Nagtegaal I; Chong I; Sadanandam A; Valeri N; Thomas K; Frost M; Brown G
Trials; 2017 Aug; 18(1):394. PubMed ID: 28851403
[TBL] [Abstract][Full Text] [Related]
12. Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Sathyakumar K; Chandramohan A; Masih D; Jesudasan MR; Pulimood A; Eapen A
Br J Radiol; 2016; 89(1060):20150328. PubMed ID: 26828967
[TBL] [Abstract][Full Text] [Related]
13. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.
Patel UB; Taylor F; Blomqvist L; George C; Evans H; Tekkis P; Quirke P; Sebag-Montefiore D; Moran B; Heald R; Guthrie A; Bees N; Swift I; Pennert K; Brown G
J Clin Oncol; 2011 Oct; 29(28):3753-60. PubMed ID: 21876084
[TBL] [Abstract][Full Text] [Related]
15. The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma.
Niu S; Chen Y; Peng F; Wen J; Xiong J; Yang Z; Peng J; Bao Y; Ding L
Front Oncol; 2023; 13():1118518. PubMed ID: 37377906
[TBL] [Abstract][Full Text] [Related]
16. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
[TBL] [Abstract][Full Text] [Related]
17. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer.
Patel UB; Brown G; Rutten H; West N; Sebag-Montefiore D; Glynne-Jones R; Rullier E; Peeters M; Van Cutsem E; Ricci S; Van de Velde C; Kjell P; Quirke P
Ann Surg Oncol; 2012 Sep; 19(9):2842-52. PubMed ID: 22526897
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging tumor response score (mrTRS) predicts therapeutic effect and prognosis of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A prospective, multi-center study.
Guan Z; Sun RJ; Cao WT; Zhang HM; Yu T; Yu XP; Zhang JX; Zhang XY; Li XT; Zhou ZY; Zhao XM; Wen L; Sun YS
Radiother Oncol; 2020 Oct; 151():288-295. PubMed ID: 32890612
[TBL] [Abstract][Full Text] [Related]
19. CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis.
Chee CG; Kim YH; Lee KH; Lee YJ; Park JH; Lee HS; Ahn S; Kim B
PLoS One; 2017; 12(8):e0182883. PubMed ID: 28797063
[TBL] [Abstract][Full Text] [Related]
20. Comparison of MRI response evaluation methods in rectal cancer: a multicentre and multireader validation study.
El Khababi N; Beets-Tan RGH; Tissier R; Lahaye MJ; Maas M; Curvo-Semedo L; Dresen RC; Nougaret S; Beets GL; Lambregts DMJ;
Eur Radiol; 2023 Jun; 33(6):4367-4377. PubMed ID: 36576549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
